Skip to search formSkip to main contentSkip to account menu

SB 236057

Known as: SB-236057 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

IndolesPyridines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
SB-236057: Critical window of sensitivity study and embryopathy of a potent musculoskeletal teratogen.
BACKGROUND SB-236057 is a potent skeletal teratogen in rodents and rabbits. The study objective was to identify the critical… 
2004
2004
Evidence for a molecular mechanism of teratogenicity of SB-236057, a 5-HT1B receptor inverse agonist that alters axial formation.
BACKGROUND SB-236057 is a potent skeletal teratogen in rodents and rabbits, producing axial and posterior somite malformations in… 
1999
1999
SB-236057, a selective 5-HT1B receptor inverse agonist, blocks the 5-HT human terminal autoreceptor.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)